NEPHROS INC Price/Book Ratio
The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.
- NEPHROS INC price/book ratio for the quarter ending 2023-12-31 was 4.36, a 104.34% increase year-over-year.
- NEPHROS INC price/book ratio for the quarter ending 2023-09-30 was 1.8, a 20.96% increase year-over-year.
- NEPHROS INC price/book ratio for the quarter ending 2023-06-30 was 1.88, a 9.67% increase year-over-year.
- NEPHROS INC price/book ratio for the quarter ending 2023-03-31 was 1.26, a 71.77% decline year-over-year.
- NEPHROS INC price/book ratio for fiscal 2023 was 4.36, a 104.34% increase from fiscal 2022.
- NEPHROS INC price/book ratio for fiscal 2022 was 2.14, a 58.73% decline from fiscal 2021.
- NEPHROS INC price/book ratio for fiscal 2021 was 5.18, a 23.50% decline from fiscal 2020.
- NEPHROS INC price/book ratio for fiscal 2020 was 6.76, a 60.56% decline from fiscal 2019.
- Available history
- 2010-12-31 to 2023-12-31
- Data captured
Historical Price/Book Ratio
Annual Price/Book Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |